An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-up.

[1]  G. Mathé,et al.  Immunopharmacology, relations, and general problems , 1980 .

[2]  G. Mathé,et al.  Cancer Chemo- and Immunopharmacology , 1980, Recent Results in Cancer Research.

[3]  J. Misset,et al.  Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. , 1978, Cancer treatment reports.

[4]  J. Misset,et al.  Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis. , 1978, Medical and pediatric oncology.

[5]  J. Misset,et al.  Leukemic (or stage V) lymphosarcoma. , 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[6]  M. Tubiana,et al.  Lymphoid Neoplasias I , 1978, Recent Results in Cancer Research.

[7]  G. Mathé,et al.  CLINICAL SIGNIFICANCE AND PROGNOSTIC VALUE OF THE T-B IMMUNOLOGICAL CLASSIFICATION OF HUMAN PRIMARY ACUTE LYMPHOID LEUKÆMIAS , 1977, The Lancet.

[8]  F. Vassal,et al.  Adriamycin in the Treatment of Acute Leukemias , 1972 .

[9]  G. Mathé.  Advances in the treatment of acute (blastic) leukemias , 1970 .

[10]  R B ROSEN,et al.  DRUGS IN HOSPITAL. , 1965, Lancet.

[11]  G. Mathé,et al.  [Trial treatment, by cyclophosphamide. of acute lymphoblastic leukemia and lymphoblastosarcoma]. , 1963, Nouvelle revue francaise d'hematologie.